These drugs include the selective serotonin reuptake inhibitors (SSRIs) and the acetylcholinesterase inhibitors (tacrine, donepezil, rivastigmine, and galantamine), which have been approved to treat depression and AD, respectively. This evidence concerns the gene ACHE and Alzheimer disease.